Taken together, the present study demonstrated that the therapeutic effects of icariin on type 1 diabetic nephropathy in rats via GPER mediated p62-dependent Keap1 degradation and Nrf2 activation. The gene discussed is KEAP1; the disease is type 1 diabetes nephropathy.